Is It Too Late to Buy Eli Lilly Stock?
Eli Lilly (NYSE: LLY) stock has soared a whopping 125% over the past year. And the big pharma player has become one of the heaviest-weighted shares in the S 500, joining the ranks of top tech companies like artificial intelligence (AI) chip giant Nvidia and iPhone maker . In fact, this drugmaker with double-digit revenue gains is starting to look more and more like a growth stock.
Why is Lilly so hot these days? The company is selling one of today's most sought-after products: weight loss drugs. But not just any weight loss drugs. Lilly commercializes a class of drugs known as glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonists. And these drugs -- Mounjaro and Zepbound -- are delivering soaring revenue as they help people worldwide shed extra pounds.
That sounds terrific, but considering Lilly's gains, you may be wondering if it's now too late to get in on this high-growth pharma stock. Let's find out.
Source Fool.com
Apple Inc. Stock
Our community is currently high on Apple Inc. with 146 Buy predictions and 17 Sell predictions.
As a result the target price of 228 € shows a slightly positive potential of 9.88% compared to the current price of 207.5 € for Apple Inc..
